A first of its kind surgery to help people with a specific type of heart failure is going through clinical trials at Providence St. Vincent’s.

Kennedy vowed to “Make America Healthy Again,” has delivered an inconsistent message that has the nation’s top infectious ...

It’s been just six months since Zevra Therapeutics scored an FD | Niemann-Pick disease type C therapy Miplyffa became ...

Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Monogram Technologies Inc. ( NASDAQ: MGRM) Q4 2024 Earnings Conference Call March 11, 2025 4:30 PM ET Larry Holub - Investor Relations Benjamin Sexson - Chief Executive Officer Noel Knape - Chief ...

US Health and Human Services secretary Robert F. Kennedy Jr. directs the Food and Drug Administration to explore revamping ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Four people have been charged in the death of a 5-year-old boy who was killed inside a pressurized oxygen chamber at a medical facility in suburban Detroit.

Joseph Shea, who sells athletic wear in Myrtle Beach, South Carolina, wonders and worries about the food he eats.

The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s ...